Effects of parabolic flight and spaceflight on the endocannabinoid system in humans

Reviews in the Neurosciences

Volumn 23, Issue 5-6, 2012, Pages 673-680

  Strewe, Claudia ^a   Feuerecker, Matthias ^a   Nichiporuk, Igor ^b   Kaufmann, Ines ^a   Hauer, Daniela ^a   Morukov, Boris ^b   Schelling, Gustav ^a   Choukèr, Alexander ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

Author keywords

2 arachidonoylglycerol; Anandamide; International Space Station; Spaceflight; Stress

Indexed keywords

ENDOCANNABINOID; HYDROCORTISONE;

ARTICLE; BLOOD SAMPLING; COSMONAUT; EMOTION; ENVIRONMENTAL STRESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KINETICS; MOTION SICKNESS; PLASMA; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; SPACE FLIGHT; STRESS;

ADAPTATION, PHYSIOLOGICAL; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLUCOCORTICOIDS; GLYCERIDES; HUMANS; MALE; MIDDLE AGED; SPACE FLIGHT; SPACE SIMULATION; STRESS, PSYCHOLOGICAL; TIME FACTORS; WEIGHTLESSNESS;

EID: 84869423408     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2012-0057     Document Type: Article

References (38)

1. Atsak, P., Hauer, D., Campolongo, P., Schelling, G., McGaugh, J.L., and Roozendaal, B. (2012). Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc. Natl. Acad. Sci. USA 109, 3504-3509.
2. Boscarino, J.A. (2008). A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom. Med. 70, 668-676.
3. Campolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., McGaugh, J.L., and Cuomo, V. (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc. Natl. Acad. Sci. USA 106, 4888-4893.
4. Centonze, D., Battistini, L., and Maccarrone, M. (2008). The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Curr. Pharm. Des. 14, 2370-2382.
5. Chouker, A. (2012) Stress Challenges and Immunity in Space (Auflage: Springer Berlin Heidelberg) (10 January 2012).
6. Chouker, A., Kaufmann, I., Kreth, S., Hauer, D., Feuerecker, M., Thieme, D., Vogeser, M., Thiel, M., and Schelling, G. (2010). Motion sickness, stress and the endocannabinoid system. PLoS ONE 5, e10752.
7. Chouker, A., Thiel, M., Baranov, V., Meshkov, D., Kotov, A., Peter, K., Messmer, K., and Christ, F. (2001). Simulated microgravity, psychic stress, and immune cells in men: observations during 120-day 6 degrees HDT. J. Appl. Physiol. 90, 1736-1743.
8. Di Marzo, V. (2008). Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov. 7, 438-455.
9. Dlugos, A., Childs, E., Stuhr, K.L., Hillard, C.J., and de Wit, H. (2012). Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology. [Epub ahead of print].
10. Evanson, N.K., Tasker, J.G., Hill, M.N., Hillard, C.J., and Herman, J.P. (2010). Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 151, 4811-4819.
11. Feuerecker, M., Hauer, D., Toth, R., Demetz, F., Holzl, J., Thiel, M., Kaufmann, I., Schelling, G., and Chouker, A. (2012). Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur. J. Appl. Physiol. 112, 2777-2781.
12. Gorzalka, B.B., Hill, M.N., and Hillard, C.J. (2008). Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 32, 1152-1160.
13. Heyman, E., Gamelin, F.X., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., Di Marzo, V., and Meeusen, R. (2012). Intense exercise increases circulating endocannabinoid and BDNF levels in humans - possible implications for reward and depression. Psychoneuroendocrinology 37, 844-851.
14. Hill, M.N., McLaughlin, R.J., Bingham, B., Shrestha, L., Lee, T.T., Gray, J.M., Hillard, C.J., Gorzalka, B.B., and Viau, V. (2010). Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. USA 107, 9406-9411.
15. Hill, M.N., Miller, G.E., Carrier, E.J., Gorzalka, B.B., and Hillard, C.J. (2009). Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34, 1257-1262.
16. Ho, W.S., Barrett, D.A., and Randall, M.D. (2008). ' Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br. J. Pharmacol. 155, 837-846.
17. Kallendrusch, S., Hobusch, C., Ehrlich, A., Ziebell, S., Ueda, N., Geisslinger, G., Koch, M., and Dehghani, F. (2012). Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections. PLoS ONE 7, e33537.
18. Klein, T.W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., and Friedman, H. (2003). The cannabinoid system and immune modulation. J. Leukoc. Biol. 74, 486-496.
19. Machado Rocha, F.C., Stefano, S.C., De Cassia Haiek, R., Rosa Oliveira, L.M., and Da Silveira, D.X. (2008). Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur. J. Cancer Care 17, 431-443.
20. McEwen, B.S. (2002). Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. Metabolism 51, 2-4.
21. McEwen, B.S. and Dhabhar, F. (2002). Stress in adolescent females: relationship to autoimmune diseases. J. Adolesc. Health 30, 30-36.
22. Mueller, B. and Basler, H.D. (1993). Kurzfragebogen zur aktuellen Beanspruchung (KAB). (Belz, Germany: Weinheim).
23. Pandey, R., Mousawy, K., Nagarkatti, M., and Nagarkatti, P. (2009). Endocannabinoids and immune regulation. Pharmacol. Res. 60, 85-92.
24. Parker, L.A., Limebeer, C.L., Rock, E.M., Litt, D.L., Kwiatkowska, M., and Piomelli, D. (2009). The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). Physiol. Behav. 97, 121-124.
25. Pertwee, R.G. (2008). Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict. Biol. 13, 147-159.
26. Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R., Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., et al. (2010). International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol. Rev. 62, 588-631.
27. Riebe, C.J. and Wotjak, C.T. (2011). Endocannabinoids and stress. Stress 14, 384-397.
28. Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N.O., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., and Greasley, P.J. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152, 1092-1101.
29. Schneider, S., Askew, C.D., Brummer, V., Kleinert, J., Guardiera, S., Abel, T., and Struder, H.K. (2009). The effect of parabolic flight on perceived physical, motivational and psychological state in men and women: correlation with neuroendocrine stress parameters and electrocortical activity. Stress 12, 336-349.
30. Schneider, S., Brummer, V., Gobel, S., Carnahan, H., Dubrowski, A., and Struder, H.K. (2007). Parabolic flight experience is related to increased release of stress hormones. Eur. J. Appl. Physiol. 100, 301-308.
31. Selye, H. (1998). A syndrome produced by diverse nocuous agents. 1936. J. Neuropsychiatry Clin. Neurosci. 10, 230-231.
32. Sugamura, K., Sugiyama, S., Nozaki, T., Matsuzawa, Y., Izumiya, Y., Miyata, K., Nakayama, M., Kaikita, K., Obata, T., Takeya, M., et al. (2009). Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 119, 28-36.
33. Tanasescu, R. and Constantinescu, C.S. (2010). Cannabinoids and the immune system: an overview. Immunobiology 215, 588-597.
34. Van Sickle, M.D., Oland, L.D., Mackie, K., Davison, J.S., and Sharkey, K.A. (2003). Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G566 - G576.
35. Vogeser, M., Hauer, D., Christina Azad, S., Huber, E., Storr, M., and Schelling, G. (2006). Release of anandamide from blood cells. Clin. Chem. Lab. Med. 44, 488-491.
36. Weis, F., Beiras-Fernandez, A., Hauer, D., Hornuss, C., Sodian, R., Kreth, S., Briegel, J., and Schelling, G. (2010a). Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. Br. J. Anaest. 105, 139-144.
37. Weis, F., Beiras-Fernandez, A., Sodian, R., Kaczmarek, I., Reichart, B., Beiras, A., Schelling, G., and Kreth, S. (2010b). Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. J. Mol. Cell. Cardiol. 48, 1187-1193.
38. Yehuda, R. (2002). Post-traumatic stress disorder. N. Engl. J. Med. 346, 108-114.